sara, back to you. >> keep us posted, meg meg, thank you meg terrell.e perfect person to respond to that news white house chief medical adviser dr. anthony fauci joins us now dr. fauci, it's great to have you. what's your reaction to that decision from the fda advisory panel. are you surprised? >> no, in some respects, i'm not surprised that they didn't vote that it goes all the way down to have 16 years old. but as meg said, what's going on right now, which is going to be critical discussion, is going to be at what age will they consider making the recommendation for the third booster? is that going to be 60, 50, 40 we don't know. and that's the reason why we just need to wait and wait for the deliberation and the decision of the advisory board and then what the fda will do in taking that recommendation or not. so, there's still a lot ahead, even though we have one element of the decision, not the decision, but the recommendation and the vote, which as i mentioned, it's not totally surprising i think the critical issue is at what age will be the cutoff

like many of us, meg's family faced a series of challenges over the past 18 months. that includes a sense of isolation and 18 months of education online for her kids. now with a new school year, meg says her sense of hope and optimism are renewed. >> i love the first day of school. i love the excitement, the jitters, making my three kids pose for pictures, even if they're rolling their eyes. we do it in the same place every year under this tree. until last year, when the rain kept us on our porch. maybe a sign of what was to come. my kids, like millions across the country turned around and walked back inside. they would spend almost the entire year learning remotely. as a journalist, i brought you into my home the first day of all remote in 2020. >> i've got comer mccormick and here logging into their onclasses. >> looks like you and john have it under control. it's only 8:20. >> let's hope. >> this picture was from day two. a steady decline followed. my husband and i were both working from home, and we could barely keep up with tech support, school work, and our own

meg oliver, thank you for your reporting.ntinue to follow the developments in the case of gabby petito. the 22 year old was rememberedts gathered for her memorial on new york's long island. cbs' tom hansen is outside the funeral home, tom, as i understand it, the family actually invited the public in to today's memorial? >> reporter: that's absolutely correct, jericka. as you know from reporting on this extensively, the death and disappearance of gabby petitosi has touched people all around the country and today at her memorial there was a constant flow of people, family and friends. >> she inspired an lot of people to do what do who is best for them first. >> reporter: joseph petito spoke about his daughter at this funeral home where friends gathered to show support and grieve. >> just hoping gabby knows that she is loved and always will be loved. >> seeing that that is the way she had passed it's heartbreaking. >> reporter: abbigail and nicholas worked with her. he >> i think gabby was an extremely eccentric girl and loved

have a great weekend meg, matt and alicia >>> still ahead mortgage rates imnging and they could keepat it means for the housing market after this break this isn't just a walk up the stairs. when you have an irregular heartbeat, it's more. it's dignity. the freedom to go where you want, knowing your doctor can watch over your heart. ♪♪ >>> welcome back a sharp jump in mortgage rates as bond rates have been on the rise to diana olick with the numbers and implications >> the average rate on the popular 30-year fixed mortgage back over 3% jumping 9 basis points yesterday take a look, we started the cycle down around 2.93% a week ago. now we are at 3.13%. the move is both a reaction to the latest commentary from the federal reserve on when it will raise rates and taper its purchases of mortgage backed bonds. fed chairman pond indicated both would happen sooner. mortgage rates follow the yield on the 10-year treasury. rates are reacting to general news on covid-19 and cases improved slightly this week. one note, low rates have been helping home buyers. a report out this morning showed the

meg, thank you for breaking this all down for us. meg tirrell.atrs as meg reported, the world health organization this new variant is now of interest are you concerned? >> we're always concerned. we know this is something typical that we see through the evolution, but i think one of the most important things to point out, we know we have the tools to decrease the spread of covid. the best way to prevent the new variant is to decrease the spread of what's here already. so that means, of course, getting vaccinated if you're old enough to be eligible, wearing masks in high-risk situation, making sure that you don't go out and about while you're sick, all these things we know how to do, to help us decrease the spread of enough variants as well. >> we were talking about the vaccines tell me what you're hearing in terms of the timeline for their approval for children. i have an 8-month-old daughter it's unclear how much at risk she is because of how young she is, but whether she is somebody would be eligible at any time for a vaccine. >> yeah. it's a g

cnbc's meg tirrell covers science and medicine for us. right down the letter, meg. >> reporter: shep, it's c capturing a lot of attention it flies in the face to start offering boosters broadly next week health officials last month said pending signoff from the fda and cdc boosters will be offered to americans eight months out from their second dose. this only applies to people who got pfizer and moderna a plan for j&j will come next. at the time, u.s. health officials said that protection against severe disease could wane in the coming months and so, quote, a booster shot will be needed to maximize vaccine induced protection and prolong its durability that view is not universally held within the fda. two of the authors today which was published in the medical journal "the lancet" are key regulators of the booster. doctors gruber and kraus they both announced their retirement in part because of frustration over how the u.s. has handled the plan for the booster shots. in the letter they and 16 other scientists and universities said they lo

cnbc's senior correspondent meg tirrell is here. meg, there's unwillingness to receive some of the drugs. as you pointed out, more than 80% of people not vaccinated do not plan to get vaccinated when you ask them about their ability or willingness to take drugs if they get sick, you look at two different categories. antiviral drugs that you can take as pills and companies like pfizer and america they could be available early next year. we only asked unvac sunday nated people 21% said yes, 38% said maybe the monoclonal antibodies that monica was talking about up to 85% reduced risk of hospitalization with desk. that's what president trump took when he got sick with covid. 33% of people said they wouldn't take them. 44% say maybe. if you add up the yeses and maybes in that category. they might be willing to take the drugs who are unvaccinated >> the question now i guess is what about the boosters? it sounds like those could be available later this month >> they absolutely could about 3/4. what's interesting is the breakdown by politic

mark mclegalan but first to our health and science correspondent meg tirrell.break down the data for us. how promising is this? >> shep, one pediatrician, dr. michael anderson, saying with these results end is in sight. he called today september 20th a historic day in this pandemic. earlier on msnbc with nicolle wallace. the results show that pfizer and biontech's vaccine induces a similar immune response in kids ages 5 to 11 as it does in kids ages 16 to 25. that means they generated a similar level of anti-bodies that can neutralize the coronavirus, and it worked out well at just a third of the doze as the vaccines for kids over 12 the vaccine was well tolerated in these younger kids and side effects were similar to what that older age group experiences. there were no reports of myo already carditis, the rare heart inflamation seen more in young men after their second dose but experts note that this trial is likely too small to pick up such a rare event now the next step is for the companies to file for emergency use authorization with the fda and the vaccine

. >>> first, let's get to our science and health correspondent meg tirrell.own the votes if you could, meg. >> the committee clearly spelled what it was being asked to recommend approval for was too broad based on the evidence available. several panelists expressed concern there wasn't enough data supporting boosters for young people, especially the rare heart risk myocar diet is with these vaccines are seen mostly in young men after their second dose for people over 65 and high risk, they recommend those with high risk of exposure at their jobs be included this is far from what they said last month, expecting protection from the vaccine could diminish in the months ahead and they were prepared to offer boosters to all americans who got the pfizer or moderna vaccines starting eight months after an individual's second dose in the last few weeks it became clear the fda would only be able to evaluate pfizer's application by then. boosters from moderna and j&j will be looked at later. but the more limited recommendation is the result of clear disagreement over th

hello, meg just nine miles an hour shy of a hurricane now. it's gaining strength as it takes aim at texas tonight this is a live look at the pleasure pier in galveston, texas. not too much to see just yet but clouds and rain are rolling in national hurricane center warning the storm could bring, get this, 20 inches of rain in some areas life-threatening flash flooding and storm surge possible it warns. the system set to hit some of the same areas that hurricane harvey devastated four years ago. in louisiana, the governor also declared a state of emergency there because it is set to hit there next before going into mississippi and alabama. more than 110,000 customers in louisiana are still without power two weeks after hurricane ida hit. flooding could be worse because of the damage left behind by ida. michelle grossmann with us tracking the storm one of the concerns here is how slowly the thing's moving. >> yeah, hi there, shep. we're going to see it moving very slowly. remember a tropical system is like a sponge. it gets wrung out. we're loo

meg, give us the school on the pfizer vaccine. you can hear how excited i am.t is the timeline for when we can actually get our kids these shots because sign me up. >> yeah, the date that a lot of people are talking about right now is halloween, but that all depends on how quickly pfizer gets that application in and they said they plan to start doing that by the end of this month and then how long the fda takes to review it. there have been differing reports about how long that could be from as short as three weeks which would be really fast to perhaps four to six weeks. we will just have to see how long all of that deliberation takes, but scott gottlieb who is on the board of pfizer, former fda commissioner this morning on cnbc was saying end of october, early november could be what we are looking at for down to age five. for parents of even younger kids like me we are waiting for more data and that's supposed to come in within a month or so. >> halloween, my favorite holiday. dr. patel, what do you think? >> look, i think that just the fact that we have this

meg, thank you so much court, i'm going to ask meg which one and when she's the expert. >> i've been we've got to do. >>> ahead of the fda advisory meeting tomorrow, let's bring in two analysts covering the vaccine makers louise chen and jeff borges. this is a very interesting proposition where the outlook is for moderna, pfizer and j&j, if you believe that a booster shot is going to be recommend ed and how that impacts >> i cover both j&j and pfizer, so i'll answer for those two companies. i believe if a booster is recommended for the broader population, the adult population, then i think it could represent some meaningful upside for pfizer, because that really hasn't been put in there. for j&j it's more of an incremental positive if the fda does recommend it, then i think it puts it at another step closer to saying maybe on a seasonal basis we need to have these covid vaccines and, jeff, do you cover moderna >> no, i cover pfizer, and my colleague covers moderna okay okay i will ask you the same question what is the up side, if there is anything, for pfizer if indeed the booster sh

as meg oliver reports, first responders and locals from several communities raced to help out. >>> oh, my god. it's on its side. >> reporter: social media video recorded by a passenger shows the aftermath of this deadly derailment here in the fields between chester and joplin, montana. eight of ten cars derailed killing at least three people. dozens more were injured. amtrak says more than 150 people including 17 crew members were on board the empire builder train when it careened off the tracks saturday. >> i was laying down in my compartment on a bed, so luckily i just tumbled. >> reporter: andrew sivula was stuck in one of the cars that detached from the train. >> i heard a loud bang, and then the cars tipped. >> reporter: he and other passengers worked with first responders using ladders to reach people trapped inside the overturned cars. >> i was able to pop my window out and climb out and help other people up. and then we sat until we get some ladders and got people down. >> reporter: wayne freed was changing cars when it happened. he survived by grabbing a table bolted to the f

tirrell has more hi, meg. >> good rx providing cnbc an exclusive looks, and they do have a metric offortable going back to the doctor's office for a routine care these are essentially prescriptions where you need to go back in torrid to refill the prescriptions. in 2021, that dotted line, they started to tick up in february they tell us in in accordance with the conveniences getting rolled out more broadly. this is on a relative basis, but we have seen eyelash growth drugs prescription fills, the rate go up astronomically in the spring of 2021 we spoke with a license the aesthetician about this. the kind of drug is called la dtisse, and some of the could be contributed to wearing masks. >> you're left with just the eyes it's not only just the eyes you want to look pretty, it's just the eyes are your only way to communication with people. before you had the smiles and the lips and the facial expressions, and now you just have your eyes that's about the only thing can you do for yourself. >> society is changing masks, causing people to get eyelash growth drugs on a slightly less upbeat

meg oliver, thank you. there is breaking news in the britney spears case tonight.ser to winning herdend. spears is getting incredible support from her fans outside the l.a. courthouse. cbs' lilia luciano is covering the hein ( cheers and applause ) >> reporter: members of the "free britney" movement are rejoicing tonight-- their favorite pop star finally gets justice. a judge ruled today that britney's father, jamie spears, is suspended as conservator, effective immediately. a temporary replacement has been named to manage her financial affairs. jamie spears has had control over his daughter's financesis since 2008, and nearly every other aspect of her life. britney spears has told the court the conservatorship is abusive, that she's been traumatized, forced into a psychiatric program that cost her $60,000 a month, even psychiatri prevented from having a baby because she wasn't allowed to remove an i.u.d.. >> they openly talked about monitoring her. >> reporter: and now, more salacious allegations have surfaced in two new documentaries, including one by the "new yo

here is meg oliver with tonight's "eye on america." >> camden is not just the boarded-up houses you see. good morning, good to see you! there are lives. there are brilliant, beautiful scholars. good morning, george. there are families who love their kids, who are passionate about education, passionate about equity, passionate about change. >> reporter: that passion helped turn camden's failing public schools into a success story. over the schools and transformed them. this school is now the highest performing school in the area. >> if i need help, they'll step aside for me and teach me anything i need. >> reporter: the percentage of kids in this elementary school who are at or above grade level in math soared from 3% to 60%, and in reading from 4% to 50%. >> you're going to regroup, showing your 1s, okay. when you see our kids in action, and you see how much brilliance and how capable they are, you understand not to limit them. >> reporter: it's all part of camden's "second act," with the creation of what are called creation of what a renaissance schools, like camden prep. unlike most o

cbs' meg oliver on what's being done to keep everyone safe. >> reporter: this morning, natalya murakhver couldn't wait to take her seven and eleven- year-old daughters back to school. >> i think it is more than safe to send kids back to school.h they miss socialization, they miss learning, they miss the interaction with their friends. >> reporter: after 18 months of pandemic shutdowns plus remote and hybrid learning... >> we're going to do it, we're ready. >> reporter: ...new york city school'shanclor isha porteralledareing a mistone,ith maskriers an vaccine man dates for teachers are safe. despite all of that, there are nervous parents how do you reassure them it's safe to send them back to school. >> we all agree the best learning happens in person between students and teachers and we have done the work to get our building safe to get them ready. >> reporter: still, some concerned parents marched to demand remote learning option on sunday. >> love you. have a great day. >> reporter: daniel cohen has mixed emotions about sending his nine-year-old son back to class. >> a sense of relief

meg, break down the pfizer data, and where does it go from here >> shep, pfizer and its barn, biontech, tested a lower dose for kids 5 to 12 it's a third the dose adults and kids over 12 receive what they foundin is that the vaccine generated an immune response at this lower dose that's comparable to people 16 to 25 at the higher dose they also said the vaccine appeared to be safe and well tolerated in kids with side effects generally similar to what you'd see in that older age group. now, the next step is the full submission for emergency use authorization and then we'll hear from the fda about when they plan a meeting of their outside advisers a key question is what the uptake in this age group will look like. 12 to 17-year-olds currently have the lowest vaccination rate of any age group with 54% having had their first shot a poll earlier this month found just more than half of kids 5 to 11 said they don't plan to get them vaccinated. many pediatricians emphasize a vaccine for kids is needed because they can experience severe disease too even though they're at lower risk than adults

he's been monitoring the chinese reaction to megs release way into the weekend here. so we're not likely to get very much in the way of official government reaction. although one foreign ministry spokesperson as alley john has left a simple message on one of the social media accounts saying welcome home. it's been left very much up to state controlled media in china to set the tone and it is one that is quite triumphal as this is being portrayed as a big win for china. and also the chinese government, the global times. for example, that is the english language mouthpiece. fairly nationalistic in tone has welcomed the release, but still very critical of canada's role in all less accusing it of doing the, the bidding of the united states illegally detaining mang. and also saying that these fraud accusations from the us were completely baseless, but also quoting experts saying that may be from this of the us and china can move on and reset relations. china still regards all of this is being completely politically motivated, that this is all part of a broader attempt by t

meg reported the biden administration taking over monoclonal antibody treatments, restricting accesssome places is that the right move >> well, look, just to take a step back. this was a foreseeable problem we knew that in the setting of a pandemic the first line of defense against a new viral contagion would be therapeutic anti-body like these drugs the these drugs have proved successful for other viruses including ebola. we also have one in development against mers, another coronavirus that was never fully developed when that coronavirus largely disappeared. we didn't have the capacity, the excess capacity in this country to scale the produsks these drugs. that's why we're dealing with the shortage that we have right now. regeneron in this case took extraordinary steps to free up the u.s. facility. moved all the manufacture of all of their drugs out of new york facility which is an enormous facility into a plant in ireland to free up that entire new york facility so they are using their entire plant in the united states to manufacture these drugs. it's still not enough so it's an a

. >>> let's focus on the big stories here bob pisa noi is here meg tirrell and ylan muoy. bob, 600 points or close to it for the dow. >> a rough week for the bulls and the bears. i just want to show you the dow jones industrial average we bottomed on monday late in the afternoon and since then the dow up 1300. half of the rally has occurred before the federal reserve started at 2:00 yesterday. bear that in mind. big question is why are we rallying so much let me show you the key points here give powell credit, he convinced the marks to not conflate tapering with the rate hikes they have confidence in an economic recovery. yes, there's help from washington on a human infrastructure package but it is about the economy. value leads. cy cyclical leads look at the numbers for travel leisure stocks same thing with energy been mediocre performer and actually hitting new highs in companies like conoco, devon, oneok and cabot. big moves up there same with the banks. 10-year yield two-month high banks sideways for months now. 4% moves the tech up but generally underperforming the ge

guys >> meg, what happens next?ke the fda? are we still thinking halloween is when kids might actually get vaccinated what does that mean in terms of logistics how the new viles will be rolled out and where? >> there are a few things that have to happen before we get the vaccine out and available to folks. first, pfizer has to file with regulators it's preparing to do that. we don't know how long that will take it could happen early october. then the question is how long will it take regulators to review it, dr. scott gottlieb suggested it might take four to six weeks. we have seen reports citing it could be shorter, three weeks. we know it's urgent right now for kids because the case numbers we are seeing is higher than ever in terms of the proportion they're making up in terms of the pandemic about 26% of overall cases in early september were kids. that compares to about 16% we've seen the entire pandemic hospitalizations are also at record so there is an urgent situation here but it will be a few weeks. we have t

good morning, meg. >> good morning, mike. outside committee of vaccine advisors meets tomorrow to discuss pfizer's booster application. before then we wanted to get a sense of how people are feeling about these, how many plan to get them we did a survey with die nate a and we found that a a lot of americans have already gotten booster shots. cdc data says 1.86 million americans since they were authorized for just people who are immunocompromised, but polling data suggests it's more than that, between 4 and 16% 16% being the dine eight a findings we asked people if they plan to get the booster, 82% said they will, 14% unsure 4% said definitely or probably will not were people thinking about changing up brands even though it is probably not going to be the recommendation until we get more study data on that? 79% said it's important to them to stick with the same brands they got the first time, whereas 21% said it's not important. in terms brands, pfizer is the most popular. however, that may have something to do with the fact t

meg terrel has more on that for us meg?e right now. there's been a lot of questions do the 14 million or so americans who've gotten j&j need a booster and if so, how much help does the booster give highly anticipated data on a trial when you give two shots of the j b & j vaccine out this morning from a press release from the company they space the doses out by two months the united states the efficacy against moderate or severe or critical covid went up to 94% when they gave these two doses two months apart globally that was 75%, perhaps reflecting some decreased efficacy because of variants around the globe they also said that the vaccine, quote, remained generally well tolerated in terms of that safety profile with two shots. now, the question here in the united states, though, for boosters is probably going to be 6 to 8 months out and j&j also looked at the antibody levels generated when you give the shots that far apart they said the six-month booster antibody levels go up 9 to 12 times compared to 4 to 6 times for a tw

just a lot swirling here a little more data about the waning immunity. >> meg, that's exactly what ia now. how time flies but this surely does suggest that, despite what you mentioned from the regulators in the lancet recently, that boosters will be helpful. >> yeah, the argument from the folks in the lancet, these fda regulators is they haven't seen convincing data yet that protection against severe disease starts to wane and this is a controlled clinical trial setting these are placebo folks who switched over to the vaccine we'll see if this adds to the strength of the data that they are looking at there a lot of the criticism of what they've looked at is real world evidence from israel we'll see all this get debated publicly on friday i'm bringing popcorn >> yeah, i was going to ask, meg, when we expect an actual fda decision on boosters on the pfizer shot, on the moderna shot and whether those are being considered differently because of different dosages and how that is going to all unfold. >> we're going to see the fda's panel of outside advisers review just pfizer's application

cnbc's meg terrell covers the medical community for us did she make the right call? >> yeah. surprisingly, there's been a mixed reaction some say it was the right thing to do to bring the cdc's recommendation in line with the f.d.a.'s authorization others said she should have stuck with the committee's vote. i also spoke today with one of the advisors who had voted against boosters for all front line workers she is from wake forest. rather than feeling like she ignored the committee that instead she actually incorporated some of their concerns into the language of the recommendation specifically, saying those at exposure risk because of their jobs may receive a booster not that they should leaving the decision making up to them and their health care providers. but critics point out just the latest in a bumpy road to this point. just more than two months ago cdc and fda said definitively that americans do not need a booster shot at that time. just more than a month later, that big announcement that all americans should get one once they're eight months from being fully vaccina

that's the key question. >> thanks, meg. >>> and thanks for watching "power lunch."s right now. >>> welcome to "closing bell." it looks lie we had be headed for a down day >> let's look at what's driving the action retail sales are coming in better than expect ed they're

so i don't know know that are in integer, but why and if i am going to google, danny was not at all meg, i'm a movie that i'm the what the grammar has to good little world rather than my little whatever. my little boy, i live mentally even getting when you get that bush and on the rub. this'll tavia is i literally to live and then change it in my check and mulligan whom i monica didn't get about what they're going to or they're going to buy ma'am. not to be live. yeah. gotta get to know when a lot of work, but in the room generated by, you know, from us, hopefully we'll be going into the over 200. got to get them on monday. he does it. i'll have him give me a call monday with me. i'll wait. now. laurel barely bought a book admitted on lower than for college and we were just in a fit of please. hello girls. can him with the in the know that monday and mega lay there. don't be a dagger going why they got the living get going. oh, i like the one that the bad on the was a long one job monday, last monday or in a boy or girl lou or don't get to the non terminating child. got my bill again th

and i am going to google, danny was on the 20 meg of i'm a movie that i'm the i tell what the grammar has to goodness a world rather than whatever marla, who do i live in the morning when i'm going to push any one on the rug this will take me a little to leave and then change the name. i checked him. i don't even whom i don't want to get about what they are. they're going to buy the man. lot of believe that. yeah. got to get to know when a lot of work in the room right. you generated by you know who you're going to be. it wouldn't bother to get them on monday. you could please have him. give me a call. monday, i me use my mouse barely bought a job, made on lower than for college and we were just in a go for the please. hello, girls can him with the little bit of money and a mega lay that the me angel dagger boy might go let me get going. oh, i like the one that the bad on the was a long one job monday. last monday, or in a boy or girl lou. or don't get to the non native shark. got my again and let me i'm tina mcdonny junior. i am well that i'm a good day i am out of in. i'm opening an

our meg tirrell is standing by to walk us through it. >>> public bab backlash in florida as the state proposed a copycat abortion bill echoing many of the same provisions included in the texas law. now congress set to enter the fight. >>> and one of china's biggest companies crumbling under a massive pile of debt the alarm bells ring in beijing and could have implications here at home. welcome to allstate. ( phone notification ) where you can pay a little less and enjoy the ride a little more. now, get new lower auto rates. you're in good hands with allstate. click or call for a lower rate today. wondering what actually goes into your multivitamin? at new chapter, you're in good hands with allstate. its' innovation, organic ingredients, and fermentation. fermentation? yes. formulated to help you body really truly absorb the natural goodness. new chapter. wellness, well done. drawing the on who should and should not get pfizer's booster shot after a long and heated debate, there is more confusion. they voted against an extra dose it applies to health care workers, teachers, grocery sto

why and if i am going to google, danny was leaving 70 meg, i'm a movie that i'm the what the grammar has to goodness a world rather than my little whatever. my little boy, i live in beginning when you get that bush and i tried the rub, this'll davy as i literally to live and then change the name. i checked her mulligan, whom i don't want to get about what they're going to or they're going to buy the man not to believe that you got to get to know when a lot of work, but in the room. right. you generate teeth, i, you know, if you're going to be going into a lot of these are 200 miles per month to get it up the we've had him miss got money. i lose weight now little barely bought a job made on lower than for college and we were just in a go for the please. hello, goals kind of with the in the know that monday and our class mega lay that the me a dagger going, what is the name of the guy i like the one that the bad on the walking along with one kid monday last monday or away. good old girl lou. oh, don't going to the non that donating child, going to my google again, the new minutes. yeah

cnbc's meg tirrell covers science for us i'm told this meeting could be a tense one. >> reporter: shepcussion the fda advisers are having tomorrow centers around whether a third dose of pfizer's vaccine is safe and effective against covid. but there's a whole lot more brewing there, including the broader question of whether booster shots are needed in general. we know both regularity laters within the fda as well as outside advisers don't believe they are that question comes down to whether protection from the vaccine wanes over time over things like hospitalization. in documents release d ahead of this meeting shots, quote, still afford protection against severe covid-19 disease and death in the united states. now, adding to potential tension tomorrow is that two key vaccine regulators have announced their planned retirements from the fda this fall. at least in part, sources say, because of frustration over how the question of boosters has been handled they also co-authored a letter in "the lancet" this week, saying booster shots are not yet needed we'll see this all play out over the